TP53 and neoplasm: The notion that tumour cells (often p53-deficient and defective in G1 arrest), unlike normal cells, rely mainly on S or G2 checkpoints mediated by CHK1 to repair their damaged DNA and preserve their genomic integrity for basic viability, supports this view (Chen et al. 2006).